» Articles » PMID: 39451320

Development of Polyvinyl Alcohol Hydrogels for Controlled Glucose Release in Biomedical Applications

Abstract

Polyvinyl alcohol (PVA) hydrogels have a wide range of applications in the pharmaceutical and biomedicine fields due to their exceptional biophysical properties. The study focuses on preparing and characterizing capsule-shaped PVA hydrogels to enhance their biocompatibility and porosity for controlled glucose release and cell proliferation. The hydrogels were prepared using different concentrations (Cs) and molecular weights (MWs) of PVA, with two different lengths, A (10 mm) and B (20 mm), to control glucose release over 60 min. The preparation process involved PVA gel preparation and PVA hydrogel formation. A total of 500 µL of glucose was injected into all dehydrated hydrogels in groups A and B. Glucose release was studied by immersing the hydrogels in saline at 37 °C with stirring at 500 rpm. The SUP-B15 cell line was grown in six A1 hydrogels for biocompatibility testing. The results indicate that all hydrogels remained stable at 37 °C without degrading. Those with a higher C and MW exhibited a denser and less porous structure, lower glucose storage capacity, and higher elongation at break. Significant differences in glucose release, diffusion speed, and flux were observed, which were more evident in A1 > A4, B1 > B4, and B1 > A1 over 60 min. A1 and B1 had higher values because their higher porosity distribution allowed glucose to diffuse more easily. B1, being larger, has more glucose due to its increased length. The cell growth response and viability at 48 h in contact with the hydrogels was similar to that of the control (4.5 × 10 cells/mL, 98.5% vs. 4.8 × 10 cells/mL, 99.7% viability), thus demonstrating biocompatibility. The hydrogels effectively released glucose over 60 min, with variations based on porosity, C, MW, and length, and demonstrated good biocompatibility with the cell line.

Citing Articles

Editorial for Special Issue "Hydrogelated Matrices: Structural, Functional and Applicative Aspects".

Gallo E, Diaferia C Gels. 2025; 11(2).

PMID: 39996690 PMC: 11854532. DOI: 10.3390/gels11020146.


Hybrid Hydrogel Supplemented with Algal Polysaccharide for Potential Use in Biomedical Applications.

Stan D, Mirica A, Mocanu S, Stan D, Podolean I, Candu N Gels. 2025; 11(1).

PMID: 39851988 PMC: 11764639. DOI: 10.3390/gels11010017.

References
1.
Zhong Y, Lin Q, Yu H, Shao L, Cui X, Pang Q . Construction methods and biomedical applications of PVA-based hydrogels. Front Chem. 2024; 12:1376799. PMC: 10905748. DOI: 10.3389/fchem.2024.1376799. View

2.
Cascone M, Lazzeri L, Sparvoli E, Scatena M, Serino L, Danti S . Morphological evaluation of bioartificial hydrogels as potential tissue engineering scaffolds. J Mater Sci Mater Med. 2005; 15(12):1309-13. DOI: 10.1007/s10856-004-5739-z. View

3.
Martins de Oliveira P, Bavaresco V, Silveira-Filho L, Schenka A, de Souza Vilarinho K, de Oliveira Severino E . Use of a novel polyvinyl alcohol membrane as a pericardial substitute reduces adhesion formation and inflammatory response after cardiac reoperation. J Thorac Cardiovasc Surg. 2013; 147(4):1405-10. DOI: 10.1016/j.jtcvs.2013.07.021. View

4.
Das S, Subuddhi U . Controlled delivery of ibuprofen from poly(vinyl alcohol)-poly(ethylene glycol) interpenetrating polymeric network hydrogels. J Pharm Anal. 2019; 9(2):108-116. PMC: 6460300. DOI: 10.1016/j.jpha.2018.11.007. View

5.
Qi Z, Yamamoto C, Imori N, Kinukawa A, Yang K, Yanai G . Immunoisolation effect of polyvinyl alcohol (PVA) macroencapsulated islets in type 1 diabetes therapy. Cell Transplant. 2012; 21(2-3):525-34. DOI: 10.3727/096368911X605448. View